TMO
THERMO FISHER SCIENTIFIC INC.
$472.80
-1.91%
$179.1B
No data for this timeframe.
Vol
Market Cap$179.1B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (85%)
Inst. Holders11 funds
Inst. Value$41.3B
Inst. Activity3 buys / 0 sells
Insider Activity0B / 4S
Insider Net $-$1.2M
Reddit Sentiment50° Neutral
SEC Reports7
Congressional3 trades
Recent Activity
Jul 21, 2026
earnings_calendar
TMO Q2 2026 Earnings Before Market Open — 2026-07-21
EPS est: $5.85 | Rev est: $11.6B
Jun 3, 2026
SEC
HSBC downgrades TMO to Hold — PT $540 (-19.4%)
ANALYST-DOWNGRADE — Impact 3/10
May 31, 2026
SEC
12 firms acted on TMO: Citigroup, Goldman Sachs, Keybanc, HSBC, Barclays, William Blair, Scotiabank, UBS, Scotiabank, Redburn Atlantic, Stephens & Co., Wells Fargo
ANALYST-UPGRADE — Impact 2/10
May 20, 2026
Insider
CHANDY RUBY R sold 499 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
HARRIS C MARTIN sold 499 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
Chai Nelson sold 499 shares
Director @ $0.00 ($0.00)
May 1, 2026
SEC
Citigroup upgrades TMO to Buy — PT $660 (+38%) amid cluster of 12 firms acting
ANALYST-UPGRADE — Impact 1/10
Inst.
FMR LLC — ADD
9,793,347 shares ($5.7B)
Price Targets
$602.76
+27.5% upside
Strong Buy
Current $472.80
Low $490.00
Median $600.00
High $750.00
25 analysts
$490.00
$750.00
Analyst Ratings
11Strong Buy
18Buy
5Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 3, 2026 | HSBC | DOWNGRADE | Buy → Hold |
| May 8, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| Apr 24, 2026 | Stifel | MAINTAIN | Buy → Buy |
| Apr 24, 2026 | Baird | MAINTAIN | Outperform → Outperform |
| Apr 14, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $5.72 | $5.68 — $5.75 | 7% YoY | 20 |
| Next Q | $6.37 | $6.09 — $6.60 | 10% YoY | 20 |
| Current FY | $24.86 | $24.63 — $25.03 | 9% YoY | 24 |
| Next FY | $27.26 | $26.25 — $29.07 | 10% YoY | 24 |
Latest Reports
BULLISH
ANALYST-UPGRADE
2/10
12 firms acted on TMO: Citigroup, Goldman Sachs, Keybanc, HSBC, Barclays, William Blair, Scotiabank, UBS, Scotiabank, Redburn Atlantic, Stephens & Co., Wells Fargo
May 31, 2026
BULLISH
ANALYST-UPGRADE
1/10
Citigroup upgrades TMO to Buy — PT $660 (+38%) amid cluster of 12 firms acting
May 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $19.8B | — |
| MORGAN STANLEY | $6.9B | — |
| FMR LLC | $5.7B | ADD |
| BANK OF AMERICA CORP | $3.4B | ADD |
| NORGES BANK | $3.1B | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | CHANDY RUBY | A | $0.00 |
| May 20, 2026 | HARRIS C | A | $0.00 |
| May 20, 2026 | Chai Nelson | A | $0.00 |
| May 20, 2026 | JOHNSON JENNIFER | A | $0.00 |
| May 20, 2026 | Jacks Tyler | A | $0.00 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
Congressional Trades
2 members: 2 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Dwight Evans | D | SELL | $1,001 - $15,000 |
| Ro Khanna | D | BUY | $15,001 - $50,000 |
| Ro Khanna | D | BUY | $1,001 - $15,000 |
11 institutional holders with $41.3B total value (71,355,889 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, FMR. Net buying activity: 3 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 34,133,702 | $19.8B | 47.8% | — |
| 2 | MORGAN STANLEY | 11,894,277 | $6.9B | 16.7% | — |
| 3 | FMR LLC | 9,793,347 | $5.7B | 13.7% | ADD +29.0% |
| 4 | BANK OF AMERICA CORP /DE/ | 5,945,838 | $3.4B | 8.3% | ADD +34.9% |
| 5 | NORGES BANK | 5,302,863 | $3.1B | 7.4% | NEW |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,843,654 | $1.6B | 4.0% | NEW |
| 7 | WELLS FARGO & COMPANY/MN | 1,396,833 | $809.4M | 2.0% | — |
| 8 | DODGE & COX | 25,741 | $14.9M | 0.0% | — |
| 9 | TWO SIGMA INVESTMENTS, LP | 12,600 | $7.3M | 0.0% | ADD +32.2% |
| 10 | Hillman Capital Management, Inc. | 634 | $367.4K | 0.0% | NEW |
| 11 | Olstein Capital Management, L.P. | 6,400 | $3.7K | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | ADD | 7,593,809 | 9,793,347 | +29.0% | $5.7B | 2025-Q4 |
| NORGES BANK | NEW | — | 5,302,863 | — | $3.1B | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 9,528 | 12,600 | +32.2% | $7.3M | 2025-Q4 |
| FMR LLC | ADD | 3,991,001 | 7,593,809 | +90.3% | $3.7B | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 4,031,124 | 5,439,999 | +34.9% | $2.6B | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 637,117 | 9,528 | -98.5% | $4.6M | 2025-Q3 |
| Hillman Capital Management, Inc. | NEW | — | 820 | — | $397.7K | 2025-Q3 |
| NORGES BANK | EXIT | 5,585,297 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 458,950 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 5,585,297 | — | $2.3B | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | ADD | 331,261 | 637,117 | +92.3% | $258.3M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 155,244 | 458,950 | +195.6% | $186.1M | 2025-Q2 |
| FMR LLC | TRIM | 6,337,377 | 4,642,545 | -26.7% | $2.3B | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 845,840 | 541,073 | -36.0% | $269.2M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 451,831 | 331,261 | -26.7% | $164.8M | 2025-Q1 |
| NORGES BANK | EXIT | 6,054,541 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 48,951 | 181,344 | +270.5% | $94.3M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 2,443,937 | — | $1.5B | 2024-Q3 |
19 unique insiders with 4 transactions. Net insider value: -$1.2M ($0.00 bought, $1.2M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | CHANDY RUBY R | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | HARRIS C MARTIN | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | Chai Nelson | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | JOHNSON JENNIFER M | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | Jacks Tyler | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | Keith R. Alexandra | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | Lynch Karen S | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | Spar Debora L | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | WEISLER DION J | Director | F | 80.287 | $451.79 | $36.3K |
| May 20, 2026 | WEISLER DION J | Director | A | 499 | $0.00 | $0.00 |
| May 20, 2026 | SPERLING SCOTT M | Director | A | 499 | $0.00 | $0.00 |
| Apr 27, 2026 | Pettiti Gianluca | President & COO | SELL | 400 | $462.66 | $185.1K |
| Mar 28, 2026 | Keith R. Alexandra | Director | A | 66.02 | $0.00 | $0.00 |
| Mar 28, 2026 | Lynch Karen S | Director | A | 66.02 | $0.00 | $0.00 |
| Mar 28, 2026 | JOHNSON JENNIFER M | Director | A | 66.02 | $0.00 | $0.00 |
| Mar 28, 2026 | SPERLING SCOTT M | Director | A | 89.78 | $0.00 | $0.00 |
| Mar 28, 2026 | WEISLER DION J | Director | A | 79.22 | $0.00 | $0.00 |
| Mar 11, 2026 | Shafer Michael D | Executive Vice President | SELL | 1,607 | $499.40 | $802.5K |
| Mar 5, 2026 | CASPER MARC N | Chairman & CEO | M | 4,000 | $309.63 | $1.2M |
| Mar 5, 2026 | CASPER MARC N | Chairman & CEO | M | 4,000 | $0.00 | $0.00 |
| Mar 5, 2026 | CASPER MARC N | Chairman & CEO | SELL | 20 | $503.66 | $10.1K |
| Mar 4, 2026 | CASPER MARC N | Chairman & CEO | M | 5,000 | $309.63 | $1.5M |
| Mar 4, 2026 | CASPER MARC N | Chairman & CEO | M | 5,000 | $0.00 | $0.00 |
| Mar 3, 2026 | CASPER MARC N | Chairman & CEO | M | 5,000 | $0.00 | $0.00 |
| Mar 3, 2026 | CASPER MARC N | Chairman & CEO | M | 5,000 | $309.63 | $1.5M |
| Feb 28, 2026 | Shafer Michael D | Executive Vice President | F | 97.984 | $521.11 | $51.1K |
| Feb 28, 2026 | Williamson Stephen | Retiring Sr. VP and CFO | F | 674.724 | $521.11 | $351.6K |
| Feb 28, 2026 | Holmes Joseph R. | VP & Chief Accounting Officer | F | 12.289 | $521.11 | $6.4K |
| Feb 28, 2026 | Lowery Frederick M. | Executive Vice President | F | 111.281 | $521.11 | $58.0K |
| Feb 28, 2026 | Lagarde Michel | Executive Vice President | F | 836.88 | $521.11 | $436.1K |
| Feb 28, 2026 | Pettiti Gianluca | President & COO | F | 741.71 | $521.11 | $386.5K |
| Feb 28, 2026 | CASPER MARC N | Chairman & CEO | F | 3,473.759 | $521.11 | $1.8M |
| Feb 28, 2026 | Britt Lisa P. | Sr. VP and Chief HR Officer | F | 262.67 | $521.11 | $136.9K |
| Feb 25, 2026 | Shropshire Thomas B Jr. | SVP and General Counsel | A | 978 | $0.00 | $0.00 |
| Feb 25, 2026 | Lagarde Michel | Executive Vice President & COO | A | 2,231 | $0.00 | $0.00 |
| Feb 25, 2026 | Shropshire Thomas B Jr. | SVP and General Counsel | A | 4,281 | $0.00 | $0.00 |
| Feb 25, 2026 | Shafer Michael D | Executive Vice President | A | 1,569 | $0.00 | $0.00 |
| Feb 25, 2026 | Shafer Michael D | Executive Vice President | A | 13,698 | $0.00 | $0.00 |
| Feb 25, 2026 | CASPER MARC N | Chairman & CEO | A | 32,109 | $0.00 | $0.00 |
| Feb 25, 2026 | Williamson Stephen | Sr. VP and CFO | A | 1,534 | $0.00 | $0.00 |
| Feb 25, 2026 | Lowery Frederick M. | Executive Vice President | A | 1,638 | $0.00 | $0.00 |
| Feb 25, 2026 | Holmes Joseph R. | VP & Chief Accounting Officer | A | 433 | $0.00 | $0.00 |
| Feb 25, 2026 | Holmes Joseph R. | VP & Chief Accounting Officer | A | 985 | $0.00 | $0.00 |
| Feb 25, 2026 | CASPER MARC N | Chairman & CEO | A | 7,515 | $0.00 | $0.00 |
| Feb 25, 2026 | Pettiti Gianluca | Executive Vice President | A | 2,057 | $0.00 | $0.00 |
| Feb 25, 2026 | Britt Lisa P. | Sr. VP and Chief HR Officer | A | 5,139 | $0.00 | $0.00 |
| Feb 25, 2026 | Pettiti Gianluca | Executive Vice President | A | 16,270 | $0.00 | $0.00 |
| Feb 25, 2026 | Britt Lisa P. | Sr. VP and Chief HR Officer | A | 872 | $0.00 | $0.00 |
| Feb 9, 2026 | Pettiti Gianluca | Executive Vice President | SELL | 400 | $541.20 | $216.5K |
7 SEC filing reports analyzed. Sentiment: 4 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 3.6/10.
BULLISH
ANALYST-UPGRADE
1/10
Citigroup upgrades TMO to Buy — PT $660 (+38%) amid cluster of 12 firms acting
May 1, 2026
BULLISH
ANALYST-UPGRADE
2/10
12 firms acted on TMO: Citigroup, Goldman Sachs, Keybanc, HSBC, Barclays, William Blair, Scotiabank, UBS, Scotiabank, Redburn Atlantic, Stephens & Co., Wells Fargo
May 31, 2026
BEARISH
ANALYST-DOWNGRADE
3/10
HSBC downgrades TMO to Hold — PT $540 (-19.4%)
Jun 3, 2026
NEUTRAL
DEFA14A
3/10
Thermo Fisher Scientific filed supplemental proxy solicitation materials urging shareholders to vote
May 11, 2026
BULLISH
8-K
7/10
Thermo Fisher Scientific reported strong Q1 2026 results with revenue up 6% to $11.01B and GAAP EPS
Apr 23, 2026
NEUTRAL
DEFA14A
2/10
Thermo Fisher Scientific Inc. filed a definitive proxy statement for its 2026 annual meeting, which
Apr 7, 2026
BULLISH
INST-CLUSTER
7/10
Three major institutions — Fidelity, Norges Bank, and Two Sigma — significantly increased their posi
Feb 28, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (85% buy). Based on 34 analysts: 11 strong buy, 18 buy, 5 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$602.76 mean target
+27.5% upside
Strong Buy (1.48)
$490.00 Low
$750.00 High
| Metric | Value |
|---|---|
| Current Price | $472.80 |
| Target Low | $490.00 |
| Target Mean | $602.76 |
| Target Median | $600.00 |
| Target High | $750.00 |
| # Analysts | 25 |
| Recommendation | Strong Buy (1.48) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$5.72 | $5.68 | $5.75 | 6.6% | -0.0% | 2↑ 12↓ | $11.7B | 7.8% | 20 |
| Next Q 2026-09-30 |
$6.37 | $6.09 | $6.60 | 10.0% | -0.1% | 14↑ 3↓ | $12.0B | 7.6% | 20 |
| Current FY 2026-12-31 |
$24.86 | $24.63 | $25.03 | 8.7% | -0.1% | 2↑ 0↓ | $47.8B | 7.2% | 24 |
| Next FY 2027-12-31 |
$27.26 | $26.25 | $29.07 | 9.7% | -0.4% | 0↑ 1↓ | $50.3B | 5.4% | 24 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $5.715 | |
| 7d ago | $5.718 | -0.002 |
| 30d ago | $5.717 | -0.002 |
| 60d ago | $5.730 | -0.015 |
| 90d ago | $5.815 | -0.100 |
10 analyst firms have rated this stock: 2 upgrades, 1 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 3, 2026 | HSBC | DOWNGRADE | Buy | Hold |
| May 8, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 24, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Apr 24, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 14, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Jan 30, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Jan 30, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Jan 30, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 9, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Jan 7, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Dec 15, 2025 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Dec 11, 2025 | Citigroup | UPGRADE | Neutral | Buy |
| Dec 9, 2025 | Goldman Sachs | INITIATE | — | Buy |
| Dec 8, 2025 | Keybanc | UPGRADE | Sector Weight | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 11 | 18 | 5 | 0 | 0 | 85% | |
| May 1, 2026 | 11 | 19 | 4 | 0 | 0 | 88% | |
| Apr 1, 2026 | 11 | 20 | 4 | 0 | 0 | 89% | |
| Mar 1, 2026 | 9 | 20 | 4 | 0 | 0 | 88% | |
| Feb 1, 2026 | 9 | 18 | 6 | 0 | 0 | 82% | |
| Jan 1, 2026 | 9 | 19 | 4 | 0 | 0 | 88% | |
| Dec 1, 2025 | 8 | 17 | 6 | 0 | 0 | 81% | |
| Nov 1, 2025 | 8 | 17 | 7 | 0 | 0 | 78% |
Strong BuyBuyHoldSellStrong Sell
2 members of Congress traded this stock: 2 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | Dwight Evans | D | HOUSE | SELL | $1,001 - $15,000 | Thermo Fisher Scientific Inc | May 18, 2026 (12d) |
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $15,001 - $50,000 | Thermo Fisher Scientific Inc | May 13, 2026 (31d) |
| Mar 6, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Thermo Fisher Scientific Inc | Apr 9, 2026 (35d) |
50°
Neutral
Bearish
Neutral
Bullish
2 mentions
0 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 4, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| Jun 4, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
Rotation into consumer staples/defensives - best plays?
▲ 1
💬 0
⚡ 0.5
Jul 21, 2026
earnings_calendar
TMO Q2 2026 Earnings Before Market Open — 2026-07-21
EPS est: $5.85 | Rev est: $11.6B
Jun 1, 2026
short_volume
Short Volume: TMO — 62.0% short (0.9M / 1.4M)
Short: 893,621 | Exempt: 848 | TRF Vol: 1,442,201 | Short Ratio: 62.0% | Off-exchange volume (dark pool + OTC)
May 11, 2026
dark_pool
Dark Pool: TMO — 3.9M shares, 84,479 trades
Week starting 2026-05-11. Total ATS volume: 3,901,089 shares across 84,479 trades.
May 4, 2026
dark_pool
Dark Pool: TMO — 3.4M shares, 81,029 trades
Week starting 2026-05-04. Total ATS volume: 3,375,675 shares across 81,029 trades.
Apr 27, 2026
dark_pool
Dark Pool: TMO — 2.4M shares, 81,665 trades
Week starting 2026-04-27. Total ATS volume: 2,441,894 shares across 81,665 trades.
Apr 23, 2026
earnings_calendar
TMO Q1 2026 Earnings Before Market Open — 2026-04-23
Apr 23, 2026
short_volume
Short Volume: TMO — 58.0% short (1.4M / 2.4M)
Short: 1,376,103 | Exempt: 23,099 | TRF Vol: 2,374,061 | Short Ratio: 58.0% | Off-exchange volume (dark pool + OTC)
Apr 21, 2026
earnings_calendar
TMO Q1 2026 Earnings Before Market Open — 2026-04-21
EPS est: $5.30 | Rev est: $11.0B
Apr 20, 2026
dark_pool
Dark Pool: TMO — 4.4M shares, 111,763 trades
Week starting 2026-04-20. Total ATS volume: 4,386,093 shares across 111,763 trades.
Apr 15, 2026
short_volume
Short Volume: TMO — 59.8% short (0.4M / 0.7M)
Short: 412,138 | Exempt: 345 | TRF Vol: 688,693 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: TMO — 59.6% short (0.6M / 0.9M)
Short: 551,467 | Exempt: 493 | TRF Vol: 925,579 | Short Ratio: 59.6% | Off-exchange volume (dark pool + OTC)
Apr 13, 2026
short_volume
Short Volume: TMO — 57.6% short (0.3M / 0.6M)
Short: 347,189 | Exempt: 13 | TRF Vol: 602,293 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
Apr 13, 2026
dark_pool
Dark Pool: TMO — 2.7M shares, 79,607 trades
Week starting 2026-04-13. Total ATS volume: 2,742,264 shares across 79,607 trades.
Apr 6, 2026
dark_pool
Dark Pool: TMO — 1.9M shares, 63,984 trades
Week starting 2026-04-06. Total ATS volume: 1,930,719 shares across 63,984 trades.
Mar 30, 2026
dark_pool
Dark Pool: TMO — 2.1M shares, 59,381 trades
Week starting 2026-03-30. Total ATS volume: 2,113,915 shares across 59,381 trades.